Metagenomi Therapeutics Inc Share Price Today: Live Updates & Key Insights
Metagenomi Therapeutics Inc share price today is $1.44, up -3.4%. The stock opened at $1.47 against the previous close of $1.47, with an intraday high of $1.47 and low of $1.39.
Metagenomi Therapeutics Inc Share Price Chart
Metagenomi Therapeutics Inc
Metagenomi Therapeutics Inc Share Price Performance
Metagenomi Therapeutics Inc Institutional Holdings
Metagenomi Therapeutics Inc Market Status
Metagenomi Therapeutics Inc Fundamentals
Market Cap 53.42 M
PB Ratio 0.3463
PE Ratio 0.0
Enterprise Value -66.72 M
Total Assets 221.10 M
Volume 182303
Metagenomi Therapeutics Inc Company Financials
About Metagenomi Therapeutics Inc & investment objective
Company Information Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Organisation Biotechnology
Employees 119
Industry Biotechnology
CEO Dr. Jian Irish M.B.A., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Metagenomi Therapeutics Inc FAQs
What is the share price of Metagenomi Therapeutics Inc today?
The current share price of Metagenomi Therapeutics Inc is $1.44.
Can I buy Metagenomi Therapeutics Inc shares in India?
Yes, Indian investors can buy Metagenomi Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Metagenomi Therapeutics Inc shares in India?
You can easily invest in Metagenomi Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Metagenomi Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Metagenomi Therapeutics Inc.
Can I buy fractional shares of Metagenomi Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Metagenomi Therapeutics Inc?
Metagenomi Therapeutics Inc has a market cap of $53.42 M.
In which sector does Metagenomi Therapeutics Inc belong?
Metagenomi Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Metagenomi Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Metagenomi Therapeutics Inc?
The PE ratio of Metagenomi Therapeutics Inc is N/A and the PB ratio is 0.35.